All of these assume an organization has defined a list of standardized gtt concentrations and limit to one concentrations unless there is a clinically essential need to have 2 standardized concentration of a drug -
1. For drugs in which you have more than one gtt concentration, does your organization use any associated nomenclature (e.g. standard vs. concentrated concentration)? Hesitant asking that since the terms are arbitrary vs. actual concentration values are objective - but still interested in what your practice is.
2. What are your labeling requirements re: different gtt concentrations?
a. Other than the numerical values, do you use any specific wording on med label, eMAR, smart pump library, and auxiliary labels to distinguish organizationally approved standard vs. concentrated concentration? If aux label, what does label read?
b. Do you affix "non-standard concentration" aux labels or something similar in rare case that a custom concentration of something is clinically imperative?
I don't see the nomenclature issue (e.g. "standard" vs. "concentrated" noted in ASHP S4S. Other resources to guide decision making?
Thanks!